Agran Libbie Lowers stake in HCP (HCP)

HCP (HCP) : Agran Libbie reduced its stake in HCP by 0.44% during the most recent quarter end. The investment management company now holds a total of 243,654 shares of HCP which is valued at $8,418,246 after selling 1,073 shares in HCP , the firm said in a disclosure report filed with the SEC on May 2, 2016.HCP makes up approximately 2.16% of Agran Libbie’s portfolio.

HCP opened for trading at $34.12 and hit $34.7 on the upside on Friday, eventually ending the session at $34.55, with a gain of 0.96% or 0.33 points. The heightened volatility saw the trading volume jump to 39,35,857 shares. Company has a market cap of $16,084 M.

Other Hedge Funds, Including , Capital Fund Management S.a. added HCP to its portfolio by purchasing 33,666 company shares during the most recent quarter which is valued at $1,163,160. HCP makes up approx 0.02% of Capital Fund Management S.a.’s portfolio.Commonwealth Equity Services Inc boosted its stake in HCP in the latest quarter, The investment management firm added 38,535 additional shares and now holds a total of 380,924 shares of HCP which is valued at $12,886,659. HCP makes up approx 0.11% of Commonwealth Equity Services Inc’s portfolio.Miller Howard Investments Inc Ny reduced its stake in HCP by selling 152,358 shares or 8.6% in the most recent quarter. The Hedge Fund company now holds 1,618,274 shares of HCP which is valued at $54,632,930. HCP makes up approx 0.97% of Miller Howard Investments Inc Ny’s portfolio.

On the company’s financial health, HCP reported $0.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Feb 9, 2016. Analyst had a consensus of $0.78. The company had revenue of $668.00 million for the quarter, compared to analysts expectations of $641.48 million. The company’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. UBS Downgraded HCP on Mar 16, 2016 to ” Neutral”, Price Target of the shares are set at $31.Shares were Reiterated by Barclays on Mar 10, 2016 to “Underweight” and Lowered the Price Target to $ 33 from a previous price target of $37 .Stifel Downgraded HCP on Feb 11, 2016 to ” Sell”, Price Target of the shares are set at $23.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Leave a Reply

HCP - Is it time to Sell?

Top Brokerage Firms are advising their investors on HCP. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.